Illumina

Youtube Subscribe

Open: 116.22 Close: 112.94 Change: -3.28

How to get information about Illumina without reading the whole internet.

How much time have you spent trying to decide whether investing in Illumina? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Illumina are: Illumina, investor, …

Concept Map

Semantic Network

Stock Summary

Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. The company offers sequencing and array-based instruments and consumables, which include reagents, flow.

Today's Summary

Illumina stock price fell $4.64 - or 5.6%, to close at $124 per share on October 18,23. Carl Icahn filed a complaint alleging direct and derivative claims of breaches of fiduciary duty. Icahn told the 13D Monitor Active Summit in New York that the lawsuit pertained to its acquisition of cancer test maker.

Today's News

Illumina alert: Bragar Eagel & Squire, p.c. reminds investors that a class action lawsuit has been filed against Illumina, inc. and encourages investors to contact the firm - Barrons.com. Illumina CFO tells investors at a conference this week that the company is exploring options to sell Grail. Illumina dragen bio it platform: what is new with version 3.9 updates. Additional updates in this release include streamlined CNV calling and methylation pipelines, gene fusion detection in repetitive regions, and increased ease of use of DRAGEN ORA (FASTQ compression) Illumina, Inc. (ILMN) stock: What Does the Chart Say Wednesday? Share your thoughts with iReport. Illumina is in the Health Care sector and Life Sciences Tools & Services industry. There is no upcoming split for Illumina. Illumina DNA Prep with Enrichment Dx is an FDA-regulated and EU IVDR 2017/746-compliant solution for targeted sequencing in diagnostic applications. Illumina: conditions are met for a rebound (nasdaq:ilmn) | seeking alpha (NASDAQ:ILMN) Illumina is a contrarian call. My main target price is $137/share and could increase to $180/share if Illumina manages to grow again close to double-digit rates. If you suffered a loss in Illumina during the relevant time frame, you have until January 9, 2024 to request that the Court appoint you as lead plaintiff. A securities class action lawsuit has been against Acelyrin, Inc. The action charges Illumina with violations of the federal securities laws, including omissions and fraudulent misrepresentations. The Company operates through two segments: Core Illumina and GRAIL. Illumina stock price fell $4.64 - or 5.6%, to close at $124 per share on October 18,23. On October 17, 2023, Carl Icahn filed a complaint alleging direct and derivative claims of breaches of fiduciary duty. Icahn told the 13D Monitor Active Summit in New York that the lawsuit pertained to its acquisition of cancer test maker. A class action securities lawsuit was filed against Illumina, Inc. (NASDAQ:ILMN) Class Period: May 1, 2023 – October 16, 20 23 Lead Plaintiff Deadline: January 9, 2024 Illumina, Inc. investors: Please contact the Portnoy Law Firm to recover your losses (GlobeNewswire) Illumina investors may, no later than January 9, 2024, move the Court to serve as lead plaintiff for the class, through Kessler Topaz Meltzer & Check, LLP. The class action complaint against Illumina,  Kangas v. Illumina.

Stock Profile

"Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; and whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. Further, it provides whole-genome sequencing, genotyping, NIPT, and product support services; and Galleri, a multi-cancer early detection test. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Further, it markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California."

Keywords

This document will help you to evaluate Illumina without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Illumina are: Illumina, investor, class, action, lawsuit, Inc, file, and the most common words in the summary are: illumina, sequence, news, learn, stock, product, tool, . One of the sentences in the summary was: Carl Icahn filed a complaint alleging direct and derivative claims of breaches of fiduciary duty. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #illumina #sequence #news #learn #stock #product #tool.

Read more →

Youtube Subscribe

---